Premium
LENALIDOMIDE AND RITUXIMAB REGIMEN COMBINED WITH INTRAVITREAL METHOTREXATE FOLLOWED BY LENALIDOMIDE MAINTENANCE FOR PRIMARY VITREORETINAL LYMPHOMA: A PROSPECTIVE PHASE II STUDY
Author(s) -
Zhang Y.,
Zhang X.,
Zou Dongm.,
Zhang L.,
Zhang Meif.,
Zhou D.,
Zhang W.
Publication year - 2021
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.75_2880
Subject(s) - lenalidomide , rituximab , intraocular lymphoma , medicine , regimen , methotrexate , lymphoma , phases of clinical research , oncology , multiple myeloma , toxicity
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom